HansBiomed Corporation (KOSDAQ:042520)
22,300
-750 (-3.25%)
At close: Jul 6, 2026
HansBiomed Market Cap
HansBiomed has a market cap or net worth of 364.38 billion as of July 7, 2026. Its market cap has increased by 175.07% in one year.
Market Cap
364.38B
Enterprise Value
388.41B
Revenue
110.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
22,300.00
Market Cap Chart
Since October 9, 2009, HansBiomed's market cap has increased from 49.00B to 364.38B, an increase of 643.55%. That is a compound annual growth rate of 12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 364.38B | -3.54% |
| Dec 30, 2025 | 377.76B | 229.79% |
| Dec 30, 2024 | 114.55B | -39.92% |
| Dec 28, 2023 | 190.65B | 100.91% |
| Dec 29, 2022 | 94.89B | -16.49% |
| Dec 30, 2021 | 113.63B | -16.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventage Lab | 505.87B |
| Curocell | 484.95B |
| IntoCell | 330.48B |
| IMBiologics | 325.69B |
| S.Biomedics | 256.99B |
| curacle co.,ltd. | 247.13B |
| Kangstem Biotech | 244.54B |
| NIBEC | 193.14B |